Clinical Trial Update: PTM202 and Modulation of Host Resistance to Diarrheagenic E. Coli [NA]

View source ↗

Summary

Completed clinical trial evaluating PTM202 for modulation of host resistance to diarrheagenic Escherichia coli in travelers with traveler's diarrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traveler Diarrhea

Drugs mentioned

• PTM202

Snippet

Sponsor: NIZO Food Research | Conditions: Traveler's Diarrhea | NA | Status: COMPLETED